{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:35:26Z","timestamp":1786746926997,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/jhh.2017.28","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T09:20:49Z","timestamp":1491470449000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea"],"prefix":"10.1038","volume":"31","author":[{"given":"M J","family":"Wolley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"issue":"3","key":"BFjhh201728_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.06.00042105","volume":"27","author":"J Hedner","year":"2006","unstructured":"Hedner J, Bengtsson-Bostrom K, Peker Y, Grote L, Rastam L, Lindblad U . Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 2006; 27 (3): 564\u2013570.","journal-title":"Eur Respir J"},{"issue":"8","key":"BFjhh201728_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.amjcard.2009.12.017","volume":"105","author":"LF Drager","year":"2010","unstructured":"Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010; 105 (8): 1135\u20131139.","journal-title":"Am J Cardiol"},{"issue":"20","key":"BFjhh201728_CR3","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/jama.2012.3418","volume":"307","author":"JM Marin","year":"2012","unstructured":"Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307 (20): 2169\u20132176.","journal-title":"JAMA"},{"issue":"19","key":"BFjhh201728_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Skatrud J . Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342 (19): 1378\u20131384.","journal-title":"N Engl J Med"},{"issue":"6","key":"BFjhh201728_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51 (6): 1403\u20131419.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201728_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1378\/chest.07-1170","volume":"132","author":"SC Goncalves","year":"2007","unstructured":"Goncalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007; 132 (6): 1858\u20131862.","journal-title":"Chest"},{"issue":"6","key":"BFjhh201728_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/sleep\/24.6.721","volume":"24","author":"P Lavie","year":"2001","unstructured":"Lavie P, Hoffstein V . Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 2001; 24 (6): 721\u2013725.","journal-title":"Sleep"},{"issue":"2","key":"BFjhh201728_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1378\/chest.06-1442","volume":"131","author":"MN Pratt-Ubunama","year":"2007","unstructured":"Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA . Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131 (2): 453\u2013459.","journal-title":"Chest"},{"issue":"1","key":"BFjhh201728_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1378\/chest.125.1.112","volume":"125","author":"DA Calhoun","year":"2004","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Harding SM . Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004; 125 (1): 112\u2013117.","journal-title":"Chest"},{"issue":"4","key":"BFjhh201728_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5664\/jcsm.27878","volume":"6","author":"CC Gonzaga","year":"2010","unstructured":"Gonzaga CC, Gaddam KK, Ahmed MI, Pimenta E, Thomas SJ, Harding SM et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010; 6 (4): 363\u2013368.","journal-title":"J Clin Sleep Med"},{"issue":"8","key":"BFjhh201728_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/jhh.2009.96","volume":"24","author":"K Gaddam","year":"2010","unstructured":"Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010; 24 (8): 532\u2013537.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"BFjhh201728_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/HJH.0000000000000047","volume":"32","author":"T Kasai","year":"2014","unstructured":"Kasai T, Bradley TD, Friedman O, Logan AG . Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension. J Hypertens 2014; 32 (3): 673\u2013680.","journal-title":"J Hypertens"},{"issue":"4","key":"BFjhh201728_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1378\/chest.12-0802","volume":"143","author":"E Pimenta","year":"2013","unstructured":"Pimenta E, Stowasser M, Gordon RD, Harding SM, Batlouni M, Zhang B et al. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest 2013; 143 (4): 978\u2013983.","journal-title":"Chest"},{"key":"BFjhh201728_CR14","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/HJH.0b013e328362add3","volume":"31","author":"M Wolley","year":"2013","unstructured":"Wolley M, Gordon RD, Pimenta E, Daunt N, Slater GJ, Ahmed AH et al. Repeating adrenal vein sampling when neither aldosterone\/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. J Hypertens 2013; 31: 2005\u20132009.","journal-title":"J Hypertens"},{"issue":"4","key":"BFjhh201728_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1210\/jc.2014-3676","volume":"100","author":"MJ Wolley","year":"2015","unstructured":"Wolley MJ, Gordon RD, Ahmed AH, Stowasser M . Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab 2015; 100 (4): 1477\u20131484.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201728_CR16","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2016. https:\/\/www.R-project.org\/."},{"key":"BFjhh201728_CR17","doi-asserted-by":"crossref","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB . lmerTest: Tests in Linear Mixed Effects Models. R package version 2.0-33, 2016. https:\/\/CRAN.R-project.org\/package=lmerTest.","DOI":"10.18637\/jss.v082.i13"},{"issue":"12","key":"BFjhh201728_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","volume":"19","author":"AG Logan","year":"2001","unstructured":"Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19 (12): 2271\u20132277.","journal-title":"J Hypertens"},{"issue":"6","key":"BFjhh201728_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P . Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40 (6): 892\u2013896.","journal-title":"Hypertension"},{"issue":"9628","key":"BFjhh201728_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371 (9628): 1921\u20131926.","journal-title":"Lancet"},{"issue":"1","key":"BFjhh201728_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.111.183517","volume":"59","author":"C Kopp","year":"2012","unstructured":"Kopp C, Linz P, Wachsmuth L, Dahlmann A, Horbach T, Schofl C et al. (23)Na magnetic resonance imaging of tissue sodium. Hypertension 2012; 59 (1): 167\u2013172.","journal-title":"Hypertension"},{"key":"BFjhh201728_CR22","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1038\/srep15297","volume":"5","author":"CH Wu","year":"2015","unstructured":"Wu CH, Yang YW, Hung SC, Tsai YC, Hu YH, Lin YH et al. Effect of treatment on body fluid in patients with unilateral aldosterone producing adenoma: adrenalectomy versus spironolactone. Sci Rep 2015; 5: 15297.","journal-title":"Sci Rep"},{"issue":"12","key":"BFjhh201728_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1164\/rccm.200607-927OC","volume":"174","author":"KL Chiu","year":"2006","unstructured":"Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 2006; 174 (12): 1378\u20131383.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"BFjhh201728_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1164\/rccm.200807-1076OC","volume":"179","author":"S Redolfi","year":"2009","unstructured":"Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009; 179 (3): 241\u2013246.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"BFjhh201728_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1378\/chest.11-1809","volume":"141","author":"DD Nicholl","year":"2012","unstructured":"Nicholl DD, Ahmed SB, Loewen AH, Hemmelgarn BR, Sola DY, Beecroft JM et al. Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 2012; 141 (6): 1422\u20131430.","journal-title":"Chest"},{"issue":"4","key":"BFjhh201728_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cardfail.2008.11.015","volume":"15","author":"D Yumino","year":"2009","unstructured":"Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 2009; 15 (4): 279\u2013285.","journal-title":"J Card Fail"},{"issue":"4","key":"BFjhh201728_CR27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/ndt\/gfr605","volume":"27","author":"RM Elias","year":"2012","unstructured":"Elias RM, Bradley TD, Kasai T, Motwani SS, Chan CT . Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant 2012; 27 (4): 1569\u20131573.","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"BFjhh201728_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.109.902452","volume":"121","author":"D Yumino","year":"2010","unstructured":"Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121 (14): 1598\u20131605.","journal-title":"Circulation"},{"issue":"10","key":"BFjhh201728_CR29","first-page":"2624","volume":"26","author":"A Yucel","year":"2005","unstructured":"Yucel A, Unlu M, Haktanir A, Acar M, Fidan F . Evaluation of the upper airway cross-sectional area changes in different degrees of severity of obstructive sleep apnea syndrome: cephalometric and dynamic CT study. AJNR Am J Neuroradiol 2005; 26 (10): 2624\u20132629.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"BFjhh201728_CR30","first-page":"135","volume":"16","author":"E Avrahami","year":"1995","unstructured":"Avrahami E, Englender M . Relation between CT axial cross-sectional area of the oropharynx and obstructive sleep apnea syndrome in adults. AJNR Am J Neuroradiol 1995; 16 (1): 135\u2013140.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"BFjhh201728_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5664\/jcsm.26793","volume":"3","author":"LK Brown","year":"2007","unstructured":"Brown LK . Mild obstructive sleep apnea syndrome should be treated. J Clin Sleep Med 2007; 3 (3): 259\u2013262.","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"BFjhh201728_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.26794","volume":"3","author":"MR Littner","year":"2007","unstructured":"Littner MR . Mild obstructive sleep apnea syndrome should not be treated. J Clin Sleep Med 2007; 3 (3): 263\u2013264.","journal-title":"J Clin Sleep Med"},{"issue":"20","key":"BFjhh201728_CR33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2012.4366","volume":"307","author":"F Barbe","year":"2012","unstructured":"Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, Martinez-Alonso M, Carmona C, Barcelo A et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012; 307 (20): 2161\u20132168.","journal-title":"JAMA"},{"issue":"10","key":"BFjhh201728_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016; 375 (10): 919\u2013931.","journal-title":"N Engl J Med."},{"issue":"5","key":"BFjhh201728_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50 (5): 911\u2013918.","journal-title":"Hypertension"},{"issue":"1","key":"BFjhh201728_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008; 168 (1): 80\u201385.","journal-title":"Arch Intern Med."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201728","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/jhh.2017.28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T17:11:38Z","timestamp":1647537098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFjhh201728"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2017.28","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"assertion":[{"value":"22 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EP is an employee of Bayer Pharma; however, this article reflects the views of the author and should not be construed to represent Bayer Pharma views or policies of its affiliates or its employees. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}